CATABASIS PHARMACEUTICALS INC 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Feb 16, 2016
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2016-02-11+103,000→ 103,000 totalExercise: $4.57Exp: 2026-02-10→ Common Stock (103,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 11, 2016 and is scheduled to vest over four years, with 25% of the shares vesting on the first anniversary of February 11, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.